Basic | |
---|---|
Market Cap | $9.05M |
Price | $2.93 |
52 Week Range | 2.72-98.75 |
Beta | -0.41 |
Margins | |
Gross Profit Margin | 72.32% |
Operating Profit Margin | -168.66% |
Net Profit Margin | -71.24% |
Valuation (TTM) | |
P/E Ratio | -7.58 |
Price to Sales Ratio | 0.23 |
Price to Book Ratio | -2.94 |
PEG Ratio | -0.16 |
Medical - Devices
Healthcare
501
2021-03-29T00:00:00.000Z
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
508 647 4000
11 Huron Drive, Natick, MA, 01760, US
0001964979